SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-14-002379
Filing Date
2014-05-09
Accepted
2014-05-09 12:46:16
Documents
14
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT sbfm_10q.htm 10-Q 420952
2 CERTIFICATION sbfm_ex311.htm EX-31.1 14797
3 CERTIFICATION sbfm_ex312.htm EX-31.2 14677
4 CERTIFICATION sbfm_ex32.htm EX-32 7044
5 img001.jpg GRAPHIC 17168
6 img002.jpg GRAPHIC 21385
7 img003.jpg GRAPHIC 13982
8 img004.jpg GRAPHIC 13095
  Complete submission text file 0001354488-14-002379.txt   1200911

Data Files

Seq Description Document Type Size
9 sbfm-20140331.xml EX-101.INS 34837
10 sbfm-20140331.xsd EX-101.SCH 9446
11 sbfm-20140331_cal.xml EX-101.CAL 22745
12 sbfm-20140331_def.xml EX-101.DEF 5896
13 sbfm-20140331_lab.xml EX-101.LAB 75363
14 sbfm-20140331_pre.xml EX-101.PRE 53500
Mailing Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4
Business Address 469 JEAN-TALON WEST 3RD FLOOR MONTREAL A8 H3N 1R4 514-764-9698
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52898 | Film No.: 14827946
SIC: 8742 Services-Management Consulting Services